Recruiting Trials
True North Clinical Research is currently recruiting participants for several clinical studies focused on cognitive impairment, Alzheimer’s disease, and migraine disorders.
Clinical research studies help researchers evaluate potential new treatments while advancing medical knowledge and future standards of care. Eligibility requirements vary by study, and our team can help determine whether a particular study may be appropriate for you.
A Phase 3 randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of KarXT and KarX-EC for the treatment of cognitive impairment associated with mild-to-moderate Alzheimer’s disease (MINDSET 1).
A Phase 3 study investigating the safety and effectiveness of rimegepant for the intermittent prevention of menstrual migraine in female participants between 18 and 40 years of age.
A Phase 3 multicenter, randomized, double-blind, placebo-controlled study evaluating trontinemab in individuals with early Alzheimer’s disease, including mild cognitive impairment and mild dementia due to Alzheimer’s disease.
Questions about research studies or memory testing?
